Figure 4
From: Transgenic cardiac-targeted overexpression of human thymidylate kinase
Quantitative analysis of ECHO images. LV mass was determined from ECHO images captured just before termination. Data were normalized to body weight (mg/g) and plotted as mean±s.e.m. (a) AZT treatment increased LV mass in WT and TGs, compared to vehicle-treated WTs (P<0.05). (b) LV mass remained unchanged in TGs and WTs after RCV treatment (right graph).
